Novavax signs deal with SK Bioscience for 40 mln vaccine doses for S. Korea ...Middle East

U.S. drug developer Novavax Inc said on Monday it has signed a license agreement with South Korea manufacturer SK Bioscience to produce 40 million doses of its COVID-19 vaccine for South Korea.

Hence then, the article about novavax signs deal with sk bioscience for 40 mln vaccine doses for s korea was published today ( Tuesday 16/02/2021 - 05:15 AM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novavax signs deal with SK Bioscience for 40 mln vaccine doses for S. Korea )

Also on site :

• Face it, Jewish liberals: You have no friends on the left
• The ‘Great Train Robbery’ sequel
• The New York Times feeds anti-Jew hatred with a horrific lie